-
Nutlin-3a Workflow for MDM2-P53 Research
2026-09-22
Nutlin-3a is a practical MDM2 inhibitor for connecting p53 pathway activation with cell-cycle control, apoptosis induction, and cancer-cell phenotyping. This workflow shows how to optimize dosing, separate apoptosis from ferroptosis, and extend findings into glioblastoma assays informed by the miR-18a/ALOXE3 axis.
-
Glioblastoma Apoptotic Priming and BH3-Mimetic Therapy
2026-09-21
Koessinger and colleagues show that glioblastoma, particularly its stem-like compartment, depends on elevated anti-apoptotic BCL-xL and MCL-1 activity. Their work links this apoptotic priming to therapeutic sensitivity and supports sequential BCL-2 family protein inhibition as a preclinical strategy for overcoming treatment resistance.
-
TPCA-1: A Translational IKK-2 Inhibitor Strategy
2026-09-21
TPCA-1 offers a selective way to interrogate IKK-2-dependent NF-κB signaling while keeping inflammatory transcription distinct from RIPK1-controlled apoptosis and necroptosis. This thought-leadership guide connects mechanistic biology, assay design, rheumatoid arthritis research, and translational decision-making without overstating what preclinical evidence can establish.
-
Exosomal Egr2 Protects Neurons After Ischemic Stroke
2026-09-20
This 2025 study identifies BMSC-derived exosomal Egr2 as a regulator of neuronal injury after oxygen-glucose deprivation/reoxygenation. Its mechanistic contribution is the connection of Egr2 transcriptional control of RNF8 with RNF8-dependent ubiquitination of DAPK1, providing a molecular explanation for the protective effects of BMSC exosomes in an in vitro ischemic-stroke model.
-
Eltanexor: From Nuclear Export to CRC Assays
2026-09-19
Eltanexor (KPT-8602) offers a mechanistically focused way to study XPO1 inhibition beyond cell viability. This article translates recent Wnt/β-catenin and colorectal cancer findings into practical assay-design decisions, controls, and interpretation strategies.
-
Lactate–HMGB1 Signaling in Polymicrobial Sepsis
2026-09-19
Yang and colleagues identify lactate as an active regulator of macrophage HMGB1 modification and exosomal release, rather than only a prognostic marker of sepsis severity. Their work connects lactate uptake, p300/CBP activity, GPR81–YAP–SIRT1 signaling, endothelial permeability, and survival in polymicrobial sepsis, while defining experimental opportunities for studying inflammatory mediator release.
-
TG003: A Rigorous Clk2 Assay Strategy
2026-09-18
TG003 is a Cdc2-like kinase inhibitor that connects splice-factor phosphorylation with Clk2-dependent platinum-resistance biology. This guide presents an assay framework for distinguishing alternative splicing modulation from DNA-repair and survival effects, while defining practical controls, handling parameters, and translational limitations.
-
BMS 599626 Dihydrochloride Workflow Guide
2026-09-18
Build reproducible EGFR/HER2 pathway experiments with BMS 599626 dihydrochloride, from dose-response design to phospho-receptor validation. This guide distinguishes established kinase biology from exploratory senescence applications and provides practical controls, timing, and troubleshooting steps for breast and lung cancer research.
-
Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor
2026-09-17
Z-LEHD-FMK is an irreversible caspase-9 inhibitor for investigating mitochondria-mediated apoptosis, caspase activity measurement, and cytoprotection models. Its reported activity supports pathway-dissection studies, but it should not be interpreted as a pan-caspase inhibitor or as an antiviral agent.
-
Dual-Action Kinase Inhibitors and p38α Dephosphorylation
2026-09-17
The referenced bioRxiv study shows that selected kinase inhibitors can do more than block catalysis: they can also accelerate WIP1-mediated dephosphorylation of the p38α activation loop. Structural and biochemical experiments connect this effect to an inhibitor-stabilized activation-loop conformation, suggesting a route toward kinase inhibitors with an added phosphatase-directed mode of action.
-
Probenecid: MRP Inhibition and Neuroprotection
2026-09-16
Probenecid, also known as 4-(dipropylsulfamoyl)benzoic acid, is a research inhibitor of organic anion transporters, multidrug resistance-associated proteins, and pannexin-1 channels. Its strongest research rationale combines multidrug resistance reversal in leukemia models with neuroprotection in cerebral ischemia/reperfusion injury, while its concentration, transporter selectivity, and translational limits require careful assay controls.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-15
Song and colleagues show that murine norovirus uses the host membrane-rupture factor NINJ1 to release the viral protein NS1 while also permitting broad damage-associated molecular pattern release. The study connects caspase-3 processing, NINJ1 recruitment to viral replication sites, and NS1 binding, establishing a mechanistic framework for unconventional viral protein secretion in vivo.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-09-15
Wang et al. identified clathrin-mediated, dynamin-dependent, and pH-sensitive endocytosis as an important entry route for genotype III grass carp reovirus GCRV104 in grass carp kidney cells. Their inhibitor panel, transmission electron microscopy, and quantitative PCR workflow also separated compounds that affect viral entry from those that do not, providing a practical framework for studying aquatic viral pathogenesis.
-
DHE in Redox Translation: From Superoxide to Therapy
2026-09-14
Dihydroethidium (DHE), also known as hydroethidine, can help translational researchers connect intracellular superoxide-associated fluorescence with therapeutic mechanism. This thought-leadership article uses a 2026 ultrasound-activated nanoparticle study as a case study for designing better oxidative stress assays, validating apoptosis pathways, and positioning DHE within oncology and cardiovascular research workflows.
-
Plant Autophagy and the Condensate-to-VAPV Pathway
2026-09-14
Jiang and colleagues identify a plant-specific condensates-to-VPS41-associated phagic vacuoles conversion pathway that directs autophagosomes toward vacuolar degradation. Their Arabidopsis study links ARLA1 GTPases, HOPS-associated VPS41 remodeling, SNARE coupling, and autophagic flux, while showing that this route is largely independent of the canonical RAB7 pathway.